SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-024721
Filing Date
2023-08-25
Accepted
2023-08-25 18:26:49
Documents
2
Period of Report
2023-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 10939
2 zavrl_poa.htm EX-24 6731
  Complete submission text file 0001437749-23-024721.txt   19342
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02216
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02216 (617) 744-4400
CervoMed Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUMA BIOTECHNOLOGY INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
ZAVRL FRANK (Reporting) CIK: 0001652169 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 231209648